Publications

Treatment of IL-18-binding protein biologics suppresses fibrotic progression in metabolic dysfunction-associated steatohepatitis

 80
Treatment of IL-18-binding protein biologics suppresses fibrotic progression in metabolic dysfunction-associated steatohepatitis

Tags:

Previous Article

Post Translation Modification

Next Article

Treatment of IL-18-binding protein biologics to treat liver disease

Related Posts

Force-bearing phagocytic adhesion rings mediate the phagocytosis of surface-bound particles

Force-bearing phagocytic adhesion rings mediate the pha...

 49

Structure of apolipoprotein B100 bound to the low-density lipoprotein receptor

Structure of apolipoprotein B100 bound to the low-densi...

 65

Citrullination modulation stabilizes HIF-1αto promote tumour progression

Citrullination modulation stabilizes HIF-1αto promote t...

 101